BBNX
Beta Bionics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.39
+0.28 ▲ +2.77%
🌙 3월 13일 5:45 PM ET (한국 3/14 06:45)
$10.17
-0.22 ▼ -2.08%
| Index | RUT | P/E | - | EPS (ttm) | -1.68 | Insider Own | 22.22% | Shs Outstand | 0.04B | Perf Week | -2.07% |
| Market Cap | 0.46B | Forward P/E | - | EPS next Y | -1.27% | Insider Trans | -0.7% | Shs Float | 0.03B | Perf Month | -26.42% |
| Enterprise Value | 0.25B | PEG | - | EPS next Q | -0.49 | Inst Own | 96.74% | Short Float | 16.3% | Perf Quarter | -64.41% |
| Income | -0.07B | P/S | 4.6 | EPS this Y | -8.55% | Inst Trans | -0.03% | Short Ratio | 4.35 | Perf Half Y | -59% |
| Sales | 0.10B | P/B | 1.6 | EPS next 5Y | 7.91% | ROA | -30.6% | Short Interest | 5.63M | Perf YTD | -65.9% |
| Book/sh | 6.48 | P/C | 2.1 | EPS past 3/5Y | -6.13% - | ROE | -40.26% | 52W High | -68.24% ($32.71) | Perf Year | -26% |
| Cash/sh | 4.94 | P/FCF | - | Sales past 3/5Y | 724.29% - | ROIC | -24.99% | 52W Low | 16.87% ($8.89) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -32.69% | Gross Margin | 55.4% | Volatility(W/M) | 6.6% 7.41% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.49 | Sales Y/Y TTM | 53.94% | Oper. Margin | -71.5% | ATR (14) | 0.95 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.96 | EPS Q/Q | 27.05% | Profit Margin | -73.02% | RSI (14) | 26.35 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.66 | Sales Q/Q | 57.15% | SMA20 | -15.1% ($12.24) | Beta | 5.51 | Target Price | $23.42 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2000000 | SMA50 | -35.33% ($16.07) | Rel Volume | 0.69 | Prev Close | $10.11 |
| Employees | 423 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 25.6% 5.69% | SMA200 | -48.17% ($20.05) | Avg Volume(3M) | 1.29M | Price | $10.39 |
| IPO | 2025/1/30 | Option/Short | Yes/Yes | Trades | 8909 | Volume | 894,123 | Change | 2.77% |
뉴스 로딩 중...